Thorne HealthTech Inc. (THRN)
NASDAQ: THRN
· Real-Time Price · USD
10.19
-0.01 (-0.10%)
At close: Oct 13, 2023, 10:00 PM
Revenue by Geography
Period Ending | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 |
---|---|---|---|---|---|---|---|
Domesticmember Revenue | 65.4M | 59.26M | 54.82M | 55.37M | 52.54M | 52.52M | 46.98M |
Domesticmember Revenue Growth | +10.35% | +8.09% | -0.99% | +5.39% | +0.05% | +11.78% | n/a |
Foreignmember Revenue | 7.32M | 5.98M | 4.75M | 3.05M | 3.53M | 2.15M | 2.88M |
Foreignmember Revenue Growth | +22.43% | +25.79% | +56.00% | -13.60% | +63.82% | -25.27% | n/a |
Operating Expense Breakdown
Period Ending | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Selling, General, and Administrative Revenue | 32.51M | 32.52M | 23.42M | 22.85M | 35.77M | 23.37M | 23.02M | 24.22M | 17.38M | 15.48M | 16.54M | 13.48M | 15.54M | 13.98M |
Selling, General, and Administrative Revenue Growth | -0.02% | +38.82% | +2.51% | -36.13% | +53.09% | +1.49% | -4.95% | +39.37% | +12.30% | -6.46% | +22.75% | -13.29% | +11.18% | n/a |
Research and Development Revenue | 1.51M | 1.77M | 1.9M | 1.81M | 1.74M | 1.97M | 1.66M | 2.24M | 1.14M | 907.17K | 1.1M | 552.06K | 1.58M | 989.99K |
Research and Development Revenue Growth | -15.01% | -6.61% | +4.54% | +4.08% | -11.38% | +18.84% | -25.98% | +96.95% | +25.20% | -17.63% | +99.49% | -65.09% | +59.75% | n/a |
Sales and Marketing Revenue | 10.04M | 8.94M | 3.14M | 4.51M | 17.27M | 5.73M | 5.11M | n/a | 5.05M | n/a | n/a | n/a | n/a | n/a |
Sales and Marketing Revenue Growth | +12.30% | +184.29% | -30.29% | -73.88% | +201.34% | +12.09% | n/a | -100.00% | n/a | n/a | n/a | n/a | n/a | n/a |